DaunoXome-type liposomal daunorubicin
Neutral DSPC/cholesterol 2:1 liposomes with a fully itemized per-vial composition.
Applicable scenario
Composition reference for small, neutral DSPC/cholesterol liposomes carrying daunorubicin citrate. Useful for comparing rigid DSPC membranes with EPC and sphingomyelin systems.
Import to Workspace
Open or scan to import into Workspace, jump to Modules and open this Recipe in the editor.
Formulation tables
Reviewed composition per 25 mL vial
| Component | Amount | Ratio / role |
|---|---|---|
| DSPC | 704 mg | DSPC:cholesterol 2:1 mol:mol |
| Cholesterol | 168 mg | Neutral bilayer |
| Daunorubicin base | Approximately 50 mg | DSPC:cholesterol:DNR 10:5:1 mol:mol:mol |
| Sucrose | 2125 mg | Aqueous dispersion |
| Glycine | 94 mg | Aqueous dispersion |
| Calcium chloride dihydrate | 7 mg | Aqueous dispersion |
| Aqueous dispersion | 25 mL | Approximately 45 nm mean particle size |
Source values and calculations
- DSPC:cholesterol is 2:1 mol:mol; DSPC:cholesterol:daunorubicin base is 10:5:1 mol:mol:mol.
- The reviewed lipid-to-drug weight ratio is 18.7:1 and the mean particle size is approximately 45 nm.
- All per-vial masses and the 25 mL dispersion volume are directly reported in the source.
Literature source
Bulbake U et al. Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics 9, 12 (2017).
Source locator: Table 1 and Section 3.1.2, DaunoXome
Read the original source · DOI: 10.3390/pharmaceutics9020012
Editorial source check: 2026-11-09. Verify the original publication, actual stock concentrations and local safety requirements before use. Research use only; not clinical instructions.